These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Oct 9, 2025
ESSA Pharma Inc. (NASDAQ: EPIX) ("ESSA" or the "Company") today announced the completion of XenoTherapeutics' ("Xeno") previously announced acquisition of ESSA (the "Acquisition"). Xeno...
-
Oct 6, 2025
ESSA Pharma Inc. (NASDAQ: EPIX) ("ESSA" or the "Company") is pleased to announce that its Securityholders (as defined below) have approved the acquisition of all of the issued and outstanding...
-
Sep 30, 2025
SOUTH SAN FRANCISCO, USA AND VANCOUVER, CANADA, Sept. 30, 2025 - ESSA Pharma Inc. (“ESSA,” or the “Company”) (NASDAQ: EPIX) today announced that, in connection with its previously...
-
Sep 24, 2025
Shareholders expected to receive approximately $0.12 per share in cash upon closing of transaction and up to approximately $0.14 per CVR under revised terms Further Adjourns Special Meeting to...
-
Sep 10, 2025
Adjournment to provide time for continued discussions regarding possible revised financial terms of transaction with XenoTherapeutics SOUTH SAN FRANCISCO, USA AND VANCOUVER, CANADA, Sept. 10, 2025...
-
Aug 25, 2025
SOUTH SAN FRANCISCO, USA AND VANCOUVER, CANADA, August 25, 2025 - ESSA Pharma Inc. (“ESSA,” or the “Company”) (NASDAQ: EPIX) announced on August 14, 2025 that, in connection with the...
-
Aug 14, 2025
SOUTH SAN FRANCISCO, USA AND VANCOUVER, CANADA, August 14, 2025 - ESSA Pharma Inc. (“ESSA,” or the “Company”) (NASDAQ: EPIX) today announced that, in connection with the Company’s...
-
Aug 6, 2025
SOUTH SAN FRANCISCO, USA AND VANCOUVER, CANADA, August 6, 2025 - ESSA Pharma Inc. (“ESSA,” or the “Company”) (NASDAQ: EPIX) today announced that, following the Company’s receipt of an...
-
Jul 23, 2025
SOUTH SAN FRANCISCO, USA AND VANCOUVER, CANADA, July 23, 2025 - ESSA Pharma Inc. (“ESSA,” or the “Company”) (NASDAQ: EPIX) today announced that, in connection with its previously announced...
-
Jul 14, 2025
The following questions and answers address briefly some questions that holders of common shares (“Common Shares”, and the holders of such Common Shares, the “Shareholders”) of ESSA Pharma...
